Form 4 for AXGN Axogen, Inc.
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-04 · accession 0000805928-25-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-04 | AXGN | DALE MICHAEL D | CEO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | A | A | 150,000 | $0.00 | 150,000 | D | — | — | (F1) This reflects the number of shares that vested as of December 4, 2025 upon the attainment of certain performance criteria. |